SCHEMBL1507857

SCHEMBL1507857

N#CC(c1ccccc1)c1ccc(F)cc1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.51
TDO2 P48775 1/20 0.51
ALDH1A1 P00352 8/20 0.50
SMN1; SMN2 Q16637 5/20 0.50
LMNA P02545 4/20 0.50
HTT P42858 3/20 0.50
HPGD P15428 2/20 0.50
NPSR1 Q6W5P4 2/20 0.50
USP2 O75604 1/20 0.50
ALPG P10696 2/20 0.46
TRPA1 O75762 1/20 0.37
TSHR P16473 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
AKR1C3 P42330 1/20 0.36
AKR1C1 Q04828 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29031390 0.83 ALDH1A1 (0.54) IDO1TDO2ALDH1A1SMN1; SMN2LMNA
SCHEMBL29031396 0.79 ALDH1A1 (0.39) IDO1TDO2ALDH1A1SMN1; SMN2LMNA
SCHEMBL1507854 0.79 ALDH1A1 (0.53) IDO1TDO2ALDH1A1SMN1; SMN2LMNA
SCHEMBL5052368 0.77 ALDH1A1 (0.74) ALDH1A1SMN1; SMN2LMNAHTTHPGD
Fluorobenzene SCHEMBL1444304 0.74 ALDH1A1 (0.69) IDO1TDO2ALDH1A1SMN1; SMN2LMNA
SCHEMBL25482200 0.73 IDO1 (0.56) IDO1TDO2CYP3A4CYP2D6SLC6A2
SCHEMBL30910880 0.73 IDO1 (0.56) IDO1TDO2SMN1; SMN2HTTCYP3A4
SCHEMBL14814262 0.73 IDO1 (0.56) IDO1TDO2SMN1; SMN2HTTCYP3A4
SCHEMBL181005 0.72 TSHR (0.56) ALDH1A1SMN1; SMN2LMNAHTTHPGD
SCHEMBL24804931 0.71 IDO1 (0.54) IDO1TDO2CYP3A4CYP2D6SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1911740-B1 POTASSIUM CHANNEL MODULATORS NEUROSEARCH AS (DK) 2013-02-27 EP disclosed
EP-2292595-A1 Potassium channel modulators NeuroSearch AS (DK) 2011-03-09 EP disclosed
US-7429618-B2 Potassium channel modulators NEUROSEARCH A/S (DK) 2008-09-30 US disclosed
EP-1465863-B1 POTASSIUM CHANNEL MODULATORS NEUROSEARCH AS (DK) 2008-07-09 EP disclosed
EP-1911740-A1 POTASSIUM CHANNEL MODULATORS NeuroSearch A/S (DK) 2008-04-16 EP disclosed
US-20070161607-A1 Potassium channel modulators SANIONA A/S (DK) 2007-07-12 US disclosed
US-7208527-B2 Potassium channel modulators POSEIDON PHARMACEUTICALS A/S (DK) 2007-04-24 US disclosed
US-20050009816-A1 Potassium channel modulators SANIONA A/S (DK) 2005-01-13 US disclosed
EP-1465863-A1 POTASSIUM CHANNEL MODULATORS Poseidon Pharmaceuticals A/S (DK) 2004-10-13 EP disclosed
WO-2003059873-A1 POTASSIUM CHANNEL MODULATORS POSEIDON PHARMACEUTICALS A/S (DK) 2003-07-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009816-A1 Potassium channel modulators KCNC1, KCNQ1, KCNA1 IDO1 2700/4885TDO2 4093/4885ALDH1A1 3877/4885
US-20070161607-A1 Potassium channel modulators KCNC1, KCNQ1, KCNA1 IDO1 2700/4885TDO2 4093/4885ALDH1A1 3877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.